| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 4.57e-07 | 4 | 98 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.94e-05 | 188 | 98 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.65e-04 | 22 | 98 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | tubulin binding | 2.57e-04 | 428 | 98 | 9 | GO:0015631 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR PHACTR2 ABI3BP CLASP1 KIF26B DISC1 APC SORBS1 MPRIP TIAM1 SYT11 ENAH NAV3 CAMSAP1 MAPRE2 | 2.91e-04 | 1099 | 98 | 15 | GO:0008092 |
| GeneOntologyMolecularFunction | ubiquitin-modified histone reader activity | 4.93e-04 | 7 | 98 | 2 | GO:0061649 | |
| GeneOntologyMolecularFunction | microtubule binding | 8.10e-04 | 308 | 98 | 7 | GO:0008017 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 7.55e-07 | 66 | 99 | 6 | GO:0007019 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.02e-06 | 38 | 99 | 5 | GO:0007026 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 1.70e-06 | 42 | 99 | 5 | GO:0031114 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 4.54e-06 | 51 | 99 | 5 | GO:0031111 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 6.08e-06 | 144 | 99 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 1.35e-05 | 108 | 99 | 6 | GO:0031110 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 1.67e-05 | 168 | 99 | 7 | GO:0031109 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 2.25e-05 | 176 | 99 | 7 | GO:0070507 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle recycling | 5.85e-05 | 44 | 99 | 4 | GO:1903421 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | USP36 TPR RANBP2 DISC1 NVL APC NUP214 LMNB2 MDM2 CHAMP1 JARID2 SYT11 PIK3C3 MAPRE2 DCLK1 TP53BP1 | 6.03e-05 | 1091 | 99 | 16 | GO:0033365 |
| GeneOntologyBiologicalProcess | cell junction organization | SORBS2 ABI3BP CLASP1 DISC1 PCLO DAB1 APC CNKSR2 SORBS1 SPECC1L PIP5K1C TIAM1 NFIA MAPRE2 DCLK1 | 6.09e-05 | 974 | 99 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 6.94e-05 | 89 | 99 | 5 | GO:1901880 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 8.04e-05 | 291 | 99 | 8 | GO:0032984 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.21e-04 | 100 | 99 | 5 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.52e-04 | 105 | 99 | 5 | GO:1901879 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 1.86e-04 | 59 | 99 | 4 | GO:0072698 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 1.97e-04 | 111 | 99 | 5 | GO:0036465 | |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 2.39e-04 | 63 | 99 | 4 | GO:0044380 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 3.25e-04 | 270 | 99 | 7 | GO:0007160 | |
| GeneOntologyBiologicalProcess | radial glia-guided pyramidal neuron migration | 3.38e-04 | 6 | 99 | 2 | GO:0140650 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 3.40e-04 | 69 | 99 | 4 | GO:0031113 | |
| GeneOntologyBiologicalProcess | chromatin organization | USP36 TPR SATB2 CHD3 LMNB2 NR3C1 CLOCK KANSL3 JARID2 UBN1 DOT1L UTY TP53BP1 | 3.51e-04 | 896 | 99 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle endocytosis | 5.27e-04 | 33 | 99 | 3 | GO:1900242 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 5.31e-04 | 293 | 99 | 7 | GO:0032886 | |
| GeneOntologyCellularComponent | Golgi lumen | 4.87e-08 | 109 | 99 | 8 | GO:0005796 | |
| GeneOntologyCellularComponent | microtubule end | 9.54e-07 | 38 | 99 | 5 | GO:1990752 | |
| GeneOntologyCellularComponent | postsynaptic specialization | ABI3BP DISC1 PCLO SH3GL1 CNKSR2 NR3C1 PAK6 PIP5K1C CHRNA4 TIAM1 SYT11 DCLK1 | 4.58e-06 | 503 | 99 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | ABI3BP DISC1 PCLO SH3GL1 CNKSR2 NR3C1 PAK6 PIP5K1C TIAM1 SYT11 DCLK1 | 9.55e-06 | 451 | 99 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | ABI3BP DISC1 PCLO SH3GL1 CNKSR2 NR3C1 PAK6 PIP5K1C TIAM1 SYT11 DCLK1 | 1.61e-05 | 477 | 99 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | postsynapse | CACNA1E ABI3BP DISC1 HCN1 PCLO SH3GL1 APC CNKSR2 NR3C1 PAK6 PIP5K1C CHRNA4 TIAM1 SYT11 PIK3C3 DCLK1 | 2.24e-05 | 1018 | 99 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ABI3BP DISC1 PCLO SH3GL1 CNKSR2 NR3C1 PAK6 PIP5K1C TIAM1 SYT11 DCLK1 | 3.75e-05 | 523 | 99 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.56e-04 | 107 | 99 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.56e-04 | 107 | 99 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | anchoring junction | SORBS2 CLASP1 SH3GL1 APC SORBS1 SPECC1L PIP5K1C MPRIP UBN1 TIAM1 ENAH RAI14 BIN2 MAPRE2 | 2.00e-04 | 976 | 99 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | microtubule | CLASP1 KIF26B DISC1 APC NCKAP5 CEP170 TIAM1 NAV3 CAMSAP1 MAPRE2 | 2.18e-04 | 533 | 99 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | actomyosin | 2.37e-04 | 117 | 99 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.47e-04 | 118 | 99 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | microtubule plus-end | 3.10e-04 | 28 | 99 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | phagocytic cup | 4.21e-04 | 31 | 99 | 3 | GO:0001891 | |
| GeneOntologyCellularComponent | cell body | CACNA1E SORBS2 DISC1 HCN1 PCLO DAB1 APC CNKSR2 CHRNA4 TIAM1 SYT11 AGFG1 SLC24A1 | 4.36e-04 | 929 | 99 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | glutamatergic synapse | DISC1 HCN1 PCLO SH3GL1 DAB1 APC CNKSR2 NR3C1 PIP5K1C TIAM1 PIK3C3 DCLK1 | 4.79e-04 | 817 | 99 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1E SORBS2 HCN1 PCLO DAB1 APC CNKSR2 CHRNA4 TIAM1 SYT11 AGFG1 SLC24A1 | 5.81e-04 | 835 | 99 | 12 | GO:0043025 |
| GeneOntologyCellularComponent | cell leading edge | 6.14e-04 | 500 | 99 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | lamellipodium | 7.95e-04 | 230 | 99 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic density membrane | 9.75e-04 | 10 | 99 | 2 | GO:0099147 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.02e-03 | 431 | 99 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CLASP1 KIF26B DISC1 APC NCKAP5 LMNB2 SPECC1L CEP170 TIAM1 NAV3 CAMSAP1 MAPRE2 | 1.10e-03 | 899 | 99 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.10e-03 | 164 | 99 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | microtubule organizing center | CLASP1 DISC1 APC CHD3 SORBS1 SPECC1L NR3C1 CEP170 UBN1 TIAM1 CAMSAP1 MAPRE2 | 1.33e-03 | 919 | 99 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | nuclear pore | 1.36e-03 | 101 | 99 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.36e-03 | 560 | 99 | 9 | GO:0005635 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 1.42e-03 | 12 | 99 | 2 | GO:0098892 | |
| GeneOntologyCellularComponent | actin cytoskeleton | SORBS2 SH3GL1 SORBS1 SPECC1L CTTNBP2NL MPRIP ENAH RAI14 BIN2 | 1.65e-03 | 576 | 99 | 9 | GO:0015629 |
| GeneOntologyCellularComponent | kinetochore | 1.71e-03 | 181 | 99 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1E SORBS2 ABI3BP HCN1 PCLO DAB1 APC CNKSR2 NR3C1 CHRNA4 TIAM1 SYT11 AGFG1 SLC24A1 | 1.91e-03 | 1228 | 99 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.26e-03 | 193 | 99 | 5 | GO:0000779 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 2.38e-03 | 56 | 99 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.23e-03 | 18 | 99 | 2 | GO:0044615 | |
| GeneOntologyCellularComponent | leading edge membrane | 3.25e-03 | 210 | 99 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | supramolecular fiber | SORBS2 CLASP1 KIF26B DISC1 APC NCKAP5 LMNB2 SPECC1L CEP170 TIAM1 NAV3 CAMSAP1 MAPRE2 | 3.71e-03 | 1179 | 99 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | SORBS2 CLASP1 KIF26B DISC1 APC NCKAP5 LMNB2 SPECC1L CEP170 TIAM1 NAV3 CAMSAP1 MAPRE2 | 3.92e-03 | 1187 | 99 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.99e-03 | 20 | 99 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | focal adhesion | 4.42e-03 | 431 | 99 | 7 | GO:0005925 | |
| GeneOntologyCellularComponent | distal axon | 4.64e-03 | 435 | 99 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 4.82e-03 | 22 | 99 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 4.82e-03 | 22 | 99 | 2 | GO:0098890 | |
| GeneOntologyCellularComponent | cell-substrate junction | 5.12e-03 | 443 | 99 | 7 | GO:0030055 | |
| GeneOntologyCellularComponent | growth cone | 6.22e-03 | 245 | 99 | 5 | GO:0030426 | |
| GeneOntologyCellularComponent | nuclear membrane | 6.34e-03 | 349 | 99 | 6 | GO:0031965 | |
| GeneOntologyCellularComponent | spindle | 7.09e-03 | 471 | 99 | 7 | GO:0005819 | |
| GeneOntologyCellularComponent | site of polarized growth | 7.10e-03 | 253 | 99 | 5 | GO:0030427 | |
| Domain | SEA | 5.61e-06 | 23 | 97 | 4 | PS50024 | |
| Domain | SEA_dom | 5.61e-06 | 23 | 97 | 4 | IPR000082 | |
| Domain | SEA | 4.74e-05 | 14 | 97 | 3 | SM00200 | |
| Domain | VWD | 7.24e-05 | 16 | 97 | 3 | SM00216 | |
| Domain | VWF_type-D | 7.24e-05 | 16 | 97 | 3 | IPR001846 | |
| Domain | VWFD | 7.24e-05 | 16 | 97 | 3 | PS51233 | |
| Domain | VWD | 7.24e-05 | 16 | 97 | 3 | PF00094 | |
| Domain | SOHO | 7.98e-05 | 3 | 97 | 2 | PS50831 | |
| Domain | Sorb | 7.98e-05 | 3 | 97 | 2 | SM00459 | |
| Domain | Sorb | 7.98e-05 | 3 | 97 | 2 | PF02208 | |
| Domain | SoHo_dom | 7.98e-05 | 3 | 97 | 2 | IPR003127 | |
| Domain | SEA | 1.95e-04 | 22 | 97 | 3 | PF01390 | |
| Domain | WxxW_domain | 3.95e-04 | 6 | 97 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 3.95e-04 | 6 | 97 | 2 | PF13330 | |
| Domain | CH | 5.66e-04 | 73 | 97 | 4 | PS50021 | |
| Domain | CH-domain | 6.27e-04 | 75 | 97 | 4 | IPR001715 | |
| Domain | TIL | 1.70e-03 | 12 | 97 | 2 | PF01826 | |
| Domain | C8 | 1.70e-03 | 12 | 97 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.01e-03 | 13 | 97 | 2 | IPR014853 | |
| Domain | C8 | 2.01e-03 | 13 | 97 | 2 | SM00832 | |
| Domain | RanBD | 2.01e-03 | 13 | 97 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 2.01e-03 | 13 | 97 | 2 | IPR000156 | |
| Domain | TIL_dom | 2.33e-03 | 14 | 97 | 2 | IPR002919 | |
| Domain | BAR | 2.68e-03 | 15 | 97 | 2 | SM00721 | |
| Domain | BAR | 2.68e-03 | 15 | 97 | 2 | PF03114 | |
| Domain | Glyco_hormone_CN | 2.68e-03 | 15 | 97 | 2 | IPR006208 | |
| Domain | Cys_knot | 2.68e-03 | 15 | 97 | 2 | PF00007 | |
| Domain | - | 2.68e-03 | 15 | 97 | 2 | 3.30.70.960 | |
| Domain | BAR_dom | 3.06e-03 | 16 | 97 | 2 | IPR004148 | |
| Domain | CTCK_1 | 3.87e-03 | 18 | 97 | 2 | PS01185 | |
| Domain | - | 4.27e-03 | 391 | 97 | 7 | 2.30.29.30 | |
| Domain | VWC_out | 4.31e-03 | 19 | 97 | 2 | SM00215 | |
| Domain | BAR | 4.31e-03 | 19 | 97 | 2 | PS51021 | |
| Domain | Synaptotagmin | 4.77e-03 | 20 | 97 | 2 | IPR001565 | |
| Domain | C2 | 5.67e-03 | 137 | 97 | 4 | SM00239 | |
| Domain | zf-RanBP | 5.76e-03 | 22 | 97 | 2 | PF00641 | |
| Domain | CT | 5.76e-03 | 22 | 97 | 2 | SM00041 | |
| Domain | CH | 5.78e-03 | 70 | 97 | 3 | PF00307 | |
| Domain | - | 6.01e-03 | 71 | 97 | 3 | 1.10.418.10 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.44e-15 | 16 | 71 | 8 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 6.46e-15 | 17 | 71 | 8 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.27e-13 | 23 | 71 | 8 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.01e-13 | 26 | 71 | 8 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.73e-10 | 21 | 71 | 6 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 7.51e-10 | 62 | 71 | 8 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.60e-09 | 68 | 71 | 8 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 8.07e-08 | 111 | 71 | 8 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 4.86e-07 | 140 | 71 | 8 | M27484 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.32e-07 | 60 | 71 | 6 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.72e-07 | 143 | 71 | 8 | M27275 | |
| Pathway | REACTOME_SUMOYLATION | 4.65e-06 | 189 | 71 | 8 | M27214 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.77e-05 | 109 | 71 | 6 | MM15164 | |
| Pathway | REACTOME_SUMOYLATION | 2.19e-05 | 169 | 71 | 7 | MM14919 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.83e-05 | 71 | 71 | 5 | M27394 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.55e-05 | 250 | 71 | 8 | M27554 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.25e-05 | 39 | 71 | 4 | M27238 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.95e-05 | 47 | 71 | 4 | MM14939 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.44e-04 | 53 | 71 | 4 | M27212 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | TPR RANBP2 SATB2 APC MUC16 MUC5B CHD3 NUP214 MUC12 NR3C1 MDM2 MUC17 LYPD3 MUC3A MUC4 MUC5AC TP53BP1 MUC20 | 2.82e-04 | 1475 | 71 | 18 | M19806 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.17e-04 | 65 | 71 | 4 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 5.47e-04 | 32 | 71 | 3 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 5.99e-04 | 33 | 71 | 3 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 6.55e-04 | 34 | 71 | 3 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 7.14e-04 | 35 | 71 | 3 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 7.76e-04 | 36 | 71 | 3 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 7.76e-04 | 36 | 71 | 3 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 8.41e-04 | 37 | 71 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 8.41e-04 | 37 | 71 | 3 | M27038 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 9.45e-04 | 150 | 71 | 5 | M39520 | |
| Pathway | PID_ECADHERIN_NASCENT_AJ_PATHWAY | 9.82e-04 | 39 | 71 | 3 | M156 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.00e-03 | 152 | 71 | 5 | MM15834 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.06e-03 | 40 | 71 | 3 | MM14945 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.14e-03 | 41 | 71 | 3 | M29574 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.14e-03 | 41 | 71 | 3 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.22e-03 | 42 | 71 | 3 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.31e-03 | 43 | 71 | 3 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.31e-03 | 43 | 71 | 3 | M26975 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.34e-03 | 11 | 71 | 2 | M22027 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 1.34e-03 | 11 | 71 | 2 | M22033 | |
| Pathway | PID_RANBP2_PATHWAY | 1.34e-03 | 11 | 71 | 2 | M140 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.40e-03 | 44 | 71 | 3 | M109 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.55e-03 | 99 | 71 | 4 | M27474 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.59e-03 | 46 | 71 | 3 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.69e-03 | 47 | 71 | 3 | M27395 | |
| Pathway | WP_MICROTUBULE_CYTOSKELETON_REGULATION | 1.80e-03 | 48 | 71 | 3 | M39566 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.91e-03 | 49 | 71 | 3 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.03e-03 | 50 | 71 | 3 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.14e-03 | 51 | 71 | 3 | MM15151 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 2.21e-03 | 109 | 71 | 4 | M39542 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.53e-03 | 54 | 71 | 3 | M29594 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.66e-03 | 55 | 71 | 3 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.10e-03 | 58 | 71 | 3 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.10e-03 | 58 | 71 | 3 | MM14736 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.50e-16 | 18 | 100 | 8 | 18834073 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR RANBP2 SORBS2 HIVEP1 CLASP1 TCOF1 CDK12 CHD3 NUP214 CHAMP1 CTTNBP2NL KANSL3 UBN1 NFIA PHF3 CBFA2T2 TMPO AFF1 PRG4 TP53BP1 | 7.04e-14 | 774 | 100 | 20 | 15302935 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KLF12 TCOF1 DISC1 CNKSR2 NUP214 MDM2 PIP5K1C UBN1 ZNF532 IPCEF1 CBFA2T2 AGFG1 AFF1 TSHZ1 CAMSAP1 | 1.84e-12 | 430 | 100 | 15 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PHACTR2 SORBS2 HIVEP1 CLASP1 KIF26B SH3GL1 APC SORBS1 PAK6 MPRIP CEP170 USP31 TIAM1 PIK3C3 PHF3 AGFG1 RAI14 CAMSAP1 DCLK1 | 5.00e-12 | 861 | 100 | 19 | 36931259 |
| Pubmed | TPR RANBP2 HIVEP1 ABI3BP KIF26B APC NCKAP5 SORBS1 NUP214 MUC12 SPECC1L PAK6 TSC22D1 NAV3 AGFG1 | 1.04e-11 | 486 | 100 | 15 | 20936779 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 TPR RANBP2 TCOF1 CDK12 SH3GL1 CHD3 NUP214 NR3C1 CHAMP1 MPRIP CEP170 ENAH AGFG1 TMPO RAI14 CAMSAP1 MAPRE2 TP53BP1 | 2.02e-11 | 934 | 100 | 19 | 33916271 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | CACNA1E RANBP2 CLASP1 PCLO CNKSR2 SORBS1 LMNB2 MPRIP TIAM1 TMPO DCLK1 | 7.37e-11 | 231 | 100 | 11 | 16452087 |
| Pubmed | TPR CACNA1E RANBP2 SORBS2 CLASP1 TCOF1 HCN1 APC CNKSR2 SORBS1 LMNB2 SPECC1L MPRIP CEP170 ENAH CAMSAP1 DCLK1 TP53BP1 | 2.84e-10 | 963 | 100 | 18 | 28671696 | |
| Pubmed | TPR TCOF1 CDK12 SH3GL1 SPECC1L CHAMP1 MPRIP CEP170 PHF3 ENAH TMPO RAI14 DOT1L TP53BP1 | 6.46e-10 | 549 | 100 | 14 | 38280479 | |
| Pubmed | TPR RANBP2 SATB2 HIVEP1 APC CHD3 NUP214 CHAMP1 GREB1L ZNF532 RAI14 CAMSAP1 | 3.15e-09 | 418 | 100 | 12 | 34709266 | |
| Pubmed | TPR RANBP2 SORBS2 HCN1 PCLO SH3GL1 APC CNKSR2 SORBS1 CEP170 SYT11 ENAH NAV3 SLC39A6 CAMSAP1 MAPRE2 DCLK1 TP53BP1 | 4.00e-09 | 1139 | 100 | 18 | 36417873 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 CLASP1 TCOF1 APC SORBS1 NR3C1 MDM2 MPRIP KANSL3 UBN1 AGFG1 DOT1L TP53BP1 | 1.50e-08 | 588 | 100 | 13 | 38580884 |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 30236127 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 26770020 | ||
| Pubmed | TPR SATB2 PHACTR2 TCOF1 CDK12 SORBS1 MPRIP PHF3 ENAH TMPO RAI14 TP53BP1 | 2.60e-08 | 506 | 100 | 12 | 30890647 | |
| Pubmed | 4.78e-08 | 250 | 100 | 9 | 33536335 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.85e-08 | 256 | 100 | 9 | 33397691 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | RANBP2 SATB2 ICE2 ZNF280B NR3C1 CTTNBP2NL KANSL3 CEP170 UBN1 PHF3 TMPO | 6.63e-08 | 444 | 100 | 11 | 34795231 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 TPR RANBP2 HIVEP1 CDK12 NVL CHD3 NUP214 CHAMP1 CEP170 UBN1 PHF3 AGFG1 TMPO TP53BP1 | 9.70e-08 | 954 | 100 | 15 | 36373674 |
| Pubmed | USP36 CLASP1 CDK12 CHAMP1 CTTNBP2NL KANSL3 CEP170 PHF3 CAMSAP1 MAPRE2 TP53BP1 | 1.23e-07 | 472 | 100 | 11 | 38943005 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.29e-07 | 281 | 100 | 9 | 28706196 | |
| Pubmed | CLASP1 CDK12 ICE2 NVL APC NUP214 LMNB2 CEP170 PHF3 CLPTM1 AGFG1 CAMSAP1 MAPRE2 | 1.93e-07 | 733 | 100 | 13 | 34672954 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 2.30e-07 | 5 | 100 | 3 | 11062147 | |
| Pubmed | TPR RANBP2 TCOF1 CDK12 APC CHAMP1 CTTNBP2NL ZXDA PHF3 ENAH TP53BP1 | 2.31e-07 | 503 | 100 | 11 | 16964243 | |
| Pubmed | SORBS2 CLASP1 CNKSR2 SORBS1 NUP214 PIP5K1C USP31 SYT11 PHF3 NAV3 | 2.93e-07 | 407 | 100 | 10 | 12693553 | |
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 19110483 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 TCOF1 NVL APC NUP214 MPRIP CEP170 PHF3 CAMSAP1 TP53BP1 | 5.96e-07 | 440 | 100 | 10 | 34244565 |
| Pubmed | TPR RANBP2 TCOF1 ICE2 APC CC2D1B NUP214 CEP170 TMPO RAI14 CAMSAP1 MAPRE2 | 9.47e-07 | 708 | 100 | 12 | 39231216 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR RANBP2 SATB2 LMNB2 NR3C1 MDM2 KANSL3 NFIA CBFA2T2 TSHZ1 CAMSAP1 TP53BP1 NOVA1 | 1.11e-06 | 857 | 100 | 13 | 25609649 |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 1.28e-06 | 8 | 100 | 3 | 31375530 | |
| Pubmed | 1.49e-06 | 67 | 100 | 5 | 29254152 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 2.98e-06 | 77 | 100 | 5 | 24927568 | |
| Pubmed | USP36 SATB2 CDK12 RGP1 CHAMP1 CLOCK CTTNBP2NL KANSL3 ZNF532 RAI14 | 3.10e-06 | 529 | 100 | 10 | 14621295 | |
| Pubmed | 4.98e-06 | 12 | 100 | 3 | 19090619 | ||
| Pubmed | 5.14e-06 | 86 | 100 | 5 | 37253089 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.50e-06 | 332 | 100 | 8 | 32786267 | |
| Pubmed | 5.57e-06 | 153 | 100 | 6 | 10718198 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR RANBP2 CLASP1 APC NUP214 CHAMP1 CTTNBP2NL MPRIP KANSL3 CEP170 LYPD3 TMPO RAI14 TP53BP1 | 5.68e-06 | 1155 | 100 | 14 | 20360068 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 7.27e-06 | 583 | 100 | 10 | 29844126 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | USP36 RANBP2 ICE2 SH3GL1 APC SPECC1L MPRIP CEP170 PHF3 AGFG1 CAMSAP1 | 7.79e-06 | 724 | 100 | 11 | 36232890 |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 7513696 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 8.18e-06 | 2 | 100 | 2 | 14988081 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15563276 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 8.18e-06 | 2 | 100 | 2 | 18475301 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22220206 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24317696 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 8.18e-06 | 2 | 100 | 2 | 35776514 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12424524 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18055444 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24327612 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21383990 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 8.18e-06 | 2 | 100 | 2 | 28607090 | |
| Pubmed | The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development. | 8.18e-06 | 2 | 100 | 2 | 16249175 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31030254 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 8.18e-06 | 2 | 100 | 2 | 23527003 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16540890 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 8.18e-06 | 2 | 100 | 2 | 27845589 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27435107 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23544943 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26871672 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28148261 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 14690056 | ||
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 8.18e-06 | 2 | 100 | 2 | 11587997 | |
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 8.18e-06 | 2 | 100 | 2 | 19158956 | |
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 8.18e-06 | 2 | 100 | 2 | 24722639 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 8.18e-06 | 2 | 100 | 2 | 34656442 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34058148 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18782111 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 14718370 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 8.18e-06 | 2 | 100 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 8.18e-06 | 2 | 100 | 2 | 36427316 | |
| Pubmed | Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. | 8.18e-06 | 2 | 100 | 2 | 27617574 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16763565 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 8.18e-06 | 2 | 100 | 2 | 23272068 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35255004 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25211188 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 8.18e-06 | 2 | 100 | 2 | 27729120 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 36111525 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34039610 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26673820 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 8.18e-06 | 2 | 100 | 2 | 32348677 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21980503 | ||
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 8.18e-06 | 2 | 100 | 2 | 24332705 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 9.72e-06 | 475 | 100 | 9 | 31040226 | |
| Pubmed | 9.92e-06 | 360 | 100 | 8 | 33111431 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.01e-05 | 361 | 100 | 8 | 26167880 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.02e-05 | 170 | 100 | 6 | 23314748 | |
| Pubmed | Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7. | 1.02e-05 | 15 | 100 | 3 | 29295817 | |
| Pubmed | 1.02e-05 | 15 | 100 | 3 | 31903119 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.39e-05 | 271 | 100 | 7 | 32433965 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.41e-05 | 498 | 100 | 9 | 36634849 | |
| Pubmed | SORBS2 CLASP1 PCLO SH3GL1 APC CNKSR2 CHD3 SORBS1 SPECC1L MPRIP CEP170 USP31 TMPO RAI14 DCLK1 | 1.44e-05 | 1431 | 100 | 15 | 37142655 | |
| Pubmed | USP36 ANKS6 TCOF1 APC MUC16 CNKSR2 SPECC1L TMPO RAI14 PJA1 CAMSAP1 | 1.50e-05 | 777 | 100 | 11 | 35844135 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 1.79e-05 | 111 | 100 | 5 | 22558309 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.84e-05 | 283 | 100 | 7 | 30585729 | |
| Pubmed | 1.97e-05 | 396 | 100 | 8 | 26687479 | ||
| Pubmed | 2.26e-05 | 57 | 100 | 4 | 29089450 | ||
| Interaction | YWHAH interactions | PHACTR2 SORBS2 HIVEP1 CLASP1 KIF26B SH3GL1 APC SORBS1 SPECC1L NR3C1 PAK6 CHRNA4 MPRIP CEP170 USP31 TIAM1 PIK3C3 PHF3 AGFG1 RAI14 CAMSAP1 DCLK1 | 1.40e-08 | 1102 | 99 | 22 | int:YWHAH |
| Interaction | SLFN11 interactions | TPR RANBP2 APC CHD3 NUP214 LMNB2 SPECC1L NR3C1 MPRIP TIAM1 TMPO RAI14 TP53BP1 | 3.93e-08 | 376 | 99 | 13 | int:SLFN11 |
| Interaction | TNIK interactions | TPR CACNA1E SORBS2 CLASP1 DISC1 HCN1 APC CNKSR2 LMNB2 CTTNBP2NL CEP170 DCLK1 TP53BP1 | 4.58e-08 | 381 | 99 | 13 | int:TNIK |
| Interaction | YWHAQ interactions | TPR PHACTR2 SORBS2 CLASP1 KIF26B DISC1 APC SORBS1 SPECC1L PAK6 MDM2 MPRIP CEP170 USP31 TIAM1 PIK3C3 AGFG1 TMPO RAI14 CAMSAP1 DCLK1 | 8.97e-08 | 1118 | 99 | 21 | int:YWHAQ |
| Interaction | YWHAG interactions | PHACTR2 SORBS2 HIVEP1 CLASP1 KIF26B CDK12 DISC1 SH3GL1 APC SORBS1 SPECC1L PAK6 MPRIP CEP170 USP31 TIAM1 PIK3C3 PHF3 AGFG1 RAI14 CAMSAP1 DCLK1 | 1.27e-07 | 1248 | 99 | 22 | int:YWHAG |
| Interaction | NAA40 interactions | USP36 TPR RANBP2 TCOF1 CDK12 SH3GL1 CHD3 NUP214 NR3C1 CHAMP1 MPRIP CEP170 ENAH AGFG1 TMPO RAI14 CAMSAP1 MAPRE2 TP53BP1 | 2.44e-07 | 978 | 99 | 19 | int:NAA40 |
| Interaction | YWHAZ interactions | SORBS2 HIVEP1 CLASP1 KIF26B DISC1 SH3GL1 APC CNKSR2 SORBS1 PAK6 MDM2 MPRIP CEP170 USP31 TIAM1 PIK3C3 PHF3 ENAH RAI14 CAMSAP1 DCLK1 TP53BP1 | 3.29e-07 | 1319 | 99 | 22 | int:YWHAZ |
| Interaction | AGAP2 interactions | 9.39e-07 | 210 | 99 | 9 | int:AGAP2 | |
| Interaction | RRP7A interactions | 1.17e-06 | 110 | 99 | 7 | int:RRP7A | |
| Interaction | NUP98 interactions | 1.38e-06 | 220 | 99 | 9 | int:NUP98 | |
| Interaction | SFN interactions | SORBS2 CLASP1 KIF26B APC SORBS1 NR3C1 MDM2 MPRIP CEP170 USP31 TIAM1 NFIA PHF3 CAMSAP1 MAPRE2 | 1.39e-06 | 692 | 99 | 15 | int:SFN |
| Interaction | RCOR1 interactions | TPR KLF12 RANBP2 SATB2 HIVEP1 APC CHD3 NR3C1 CLOCK RAI14 CAMSAP1 TP53BP1 | 5.51e-06 | 494 | 99 | 12 | int:RCOR1 |
| Interaction | SAA1 interactions | 6.75e-06 | 54 | 99 | 5 | int:SAA1 | |
| Interaction | SMC5 interactions | USP36 TPR RANBP2 HIVEP1 CDK12 DISC1 NVL CHD3 NUP214 CHAMP1 CEP170 UBN1 PHF3 AGFG1 TMPO PJA1 TP53BP1 | 6.91e-06 | 1000 | 99 | 17 | int:SMC5 |
| Interaction | TRIM36 interactions | 7.07e-06 | 144 | 99 | 7 | int:TRIM36 | |
| Interaction | ACTC1 interactions | TPR SATB2 PHACTR2 TCOF1 CDK12 DISC1 CHD3 SORBS1 MPRIP PHF3 ENAH TMPO RAI14 TP53BP1 | 7.35e-06 | 694 | 99 | 14 | int:ACTC1 |
| Interaction | MAPRE1 interactions | RANBP2 SORBS2 CLASP1 APC NUP214 LMNB2 SPECC1L CEP170 JARID2 NAV3 CAMSAP1 MAPRE2 | 8.23e-06 | 514 | 99 | 12 | int:MAPRE1 |
| Interaction | DYRK1A interactions | TPR TCOF1 ICE2 NUP214 MDM2 CTTNBP2NL MPRIP ENAH AFF1 RAI14 PJA1 CAMSAP1 | 1.68e-05 | 552 | 99 | 12 | int:DYRK1A |
| Interaction | MAPRE3 interactions | 1.79e-05 | 230 | 99 | 8 | int:MAPRE3 | |
| Interaction | KIFAP3 interactions | 1.90e-05 | 112 | 99 | 6 | int:KIFAP3 | |
| Interaction | KCNA3 interactions | TPR RANBP2 TCOF1 ICE2 APC CC2D1B NUP214 SPECC1L MPRIP CEP170 PHF3 TMPO RAI14 CAMSAP1 MAPRE2 | 2.20e-05 | 871 | 99 | 15 | int:KCNA3 |
| Interaction | CIC interactions | KLF12 RANBP2 SATB2 NVL GCM1 LMNB2 NR3C1 CHAMP1 NFIA PHF3 TMPO DCLK1 TP53BP1 | 2.53e-05 | 673 | 99 | 13 | int:CIC |
| Interaction | DCTN1 interactions | TPR CLASP1 DISC1 APC CC2D1B SPECC1L CEP170 DOT1L CAMSAP1 MAPRE2 DCLK1 | 3.28e-05 | 497 | 99 | 11 | int:DCTN1 |
| Interaction | YWHAB interactions | SORBS2 HIVEP1 CLASP1 KIF26B APC SORBS1 PAK6 MPRIP CEP170 USP31 TIAM1 PHF3 RAI14 DOT1L CAMSAP1 DCLK1 | 3.31e-05 | 1014 | 99 | 16 | int:YWHAB |
| Interaction | CLIP1 interactions | 3.34e-05 | 183 | 99 | 7 | int:CLIP1 | |
| Interaction | YWHAE interactions | SORBS2 HIVEP1 CLASP1 KIF26B CDK12 DISC1 APC SORBS1 PAK6 MPRIP CEP170 USP31 TIAM1 TMPO RAI14 DOT1L CAMSAP1 DCLK1 | 3.60e-05 | 1256 | 99 | 18 | int:YWHAE |
| Interaction | PHLPP1 interactions | 3.87e-05 | 333 | 99 | 9 | int:PHLPP1 | |
| Interaction | FOXL1 interactions | 5.17e-05 | 196 | 99 | 7 | int:FOXL1 | |
| Interaction | KDM1A interactions | TPR RANBP2 SATB2 HIVEP1 APC CHD3 NUP214 NR3C1 CHAMP1 CLOCK GREB1L ZNF532 RAI14 CAMSAP1 TP53BP1 | 5.35e-05 | 941 | 99 | 15 | int:KDM1A |
| Interaction | NUP43 interactions | USP36 RANBP2 HIVEP1 CDK12 APC CHD3 NUP214 CHAMP1 KANSL3 CD93 ZNF532 NFIA | 5.62e-05 | 625 | 99 | 12 | int:NUP43 |
| Interaction | SIRT6 interactions | RANBP2 TCOF1 NVL APC CHD3 NUP214 MDM2 MPRIP CEP170 PHF3 CAMSAP1 TP53BP1 | 5.88e-05 | 628 | 99 | 12 | int:SIRT6 |
| Interaction | MYCBP2 interactions | 6.34e-05 | 355 | 99 | 9 | int:MYCBP2 | |
| Interaction | HDAC4 interactions | TPR CACNA1E RANBP2 NVL APC GCM1 NUP214 PIP5K1C TIAM1 SYT11 NAV3 DCLK1 TP53BP1 | 7.07e-05 | 744 | 99 | 13 | int:HDAC4 |
| Interaction | NFIB interactions | 7.20e-05 | 142 | 99 | 6 | int:NFIB | |
| Interaction | TPR interactions | 7.40e-05 | 281 | 99 | 8 | int:TPR | |
| Interaction | CLASP2 interactions | 8.72e-05 | 147 | 99 | 6 | int:CLASP2 | |
| Interaction | SETDB1 interactions | 8.99e-05 | 214 | 99 | 7 | int:SETDB1 | |
| Interaction | MLLT10 interactions | 1.15e-04 | 51 | 99 | 4 | int:MLLT10 | |
| Interaction | APC interactions | 1.27e-04 | 389 | 99 | 9 | int:APC | |
| Interaction | H3C1 interactions | USP36 TPR CHD3 NR3C1 CHAMP1 UBN1 NFIA PHF3 NAV3 TMPO BIN2 CAMSAP1 MAPRE2 TP53BP1 | 1.27e-04 | 901 | 99 | 14 | int:H3C1 |
| Interaction | ARRB1 interactions | 1.28e-04 | 304 | 99 | 8 | int:ARRB1 | |
| Interaction | NLE1 interactions | 1.33e-04 | 228 | 99 | 7 | int:NLE1 | |
| Interaction | UQCR11 interactions | 1.33e-04 | 53 | 99 | 4 | int:UQCR11 | |
| Interaction | RAD51B interactions | 1.54e-04 | 55 | 99 | 4 | int:RAD51B | |
| Interaction | CREBBP interactions | HIVEP1 SH3GL1 APC GCM1 CHD3 NR3C1 MDM2 CLOCK TIAM1 NFIA TP53BP1 | 1.72e-04 | 599 | 99 | 11 | int:CREBBP |
| Interaction | DYNLT1 interactions | 1.88e-04 | 241 | 99 | 7 | int:DYNLT1 | |
| Interaction | DDX51 interactions | 1.93e-04 | 108 | 99 | 5 | int:DDX51 | |
| Interaction | USP7 interactions | USP36 TPR KLF12 DISC1 APC CNKSR2 PAK6 MDM2 MPRIP TSC22D1 UBN1 IPCEF1 TMPO RAI14 PJA1 CAMSAP1 UTY | 2.09e-04 | 1313 | 99 | 17 | int:USP7 |
| Interaction | CIT interactions | TPR RANBP2 SORBS2 CLASP1 TCOF1 DISC1 HCN1 PCLO NVL CHD3 LMNB2 SPECC1L CHAMP1 MPRIP CEP170 NFIA TMPO RAI14 | 2.24e-04 | 1450 | 99 | 18 | int:CIT |
| Interaction | SPTBN1 interactions | 2.29e-04 | 421 | 99 | 9 | int:SPTBN1 | |
| Interaction | WWTR1 interactions | 2.33e-04 | 422 | 99 | 9 | int:WWTR1 | |
| Interaction | CHEK2 interactions | 2.35e-04 | 250 | 99 | 7 | int:CHEK2 | |
| Interaction | CPAP interactions | 2.79e-04 | 182 | 99 | 6 | int:CPAP | |
| Interaction | PAFAH1B1 interactions | 2.84e-04 | 258 | 99 | 7 | int:PAFAH1B1 | |
| Interaction | ETV7 interactions | 3.09e-04 | 27 | 99 | 3 | int:ETV7 | |
| Interaction | HDAC1 interactions | USP36 TPR RANBP2 SATB2 HIVEP1 APC GCM1 CHD3 NUP214 NR3C1 MDM2 AFF1 RAI14 DOT1L CAMSAP1 | 3.22e-04 | 1108 | 99 | 15 | int:HDAC1 |
| Interaction | MYH9 interactions | USP36 SORBS2 HIVEP1 TCOF1 CHD3 SPECC1L MPRIP PIK3C3 PHF3 TMPO RAI14 DOT1L | 3.23e-04 | 754 | 99 | 12 | int:MYH9 |
| Interaction | NFIA interactions | 3.32e-04 | 188 | 99 | 6 | int:NFIA | |
| Interaction | EHMT1 interactions | 3.32e-04 | 188 | 99 | 6 | int:EHMT1 | |
| Interaction | CEP43 interactions | 3.52e-04 | 190 | 99 | 6 | int:CEP43 | |
| Interaction | HNF1B interactions | 3.52e-04 | 190 | 99 | 6 | int:HNF1B | |
| Interaction | RPA4 interactions | 3.86e-04 | 452 | 99 | 9 | int:RPA4 | |
| Interaction | PAXIP1 interactions | 3.93e-04 | 359 | 99 | 8 | int:PAXIP1 | |
| Interaction | TNK2 interactions | 4.04e-04 | 195 | 99 | 6 | int:TNK2 | |
| Interaction | RANBP2 interactions | 4.07e-04 | 361 | 99 | 8 | int:RANBP2 | |
| Interaction | HNF4A interactions | 4.17e-04 | 275 | 99 | 7 | int:HNF4A | |
| Interaction | SRGAP2 interactions | 4.26e-04 | 197 | 99 | 6 | int:SRGAP2 | |
| Interaction | TUBB4B interactions | USP36 TPR RANBP2 CLASP1 APC CHD3 NUP214 NR3C1 CEP170 CAMSAP1 | 4.30e-04 | 560 | 99 | 10 | int:TUBB4B |
| Interaction | ARID4B interactions | 4.50e-04 | 199 | 99 | 6 | int:ARID4B | |
| Interaction | UHRF2 interactions | 4.62e-04 | 200 | 99 | 6 | int:UHRF2 | |
| Interaction | NHP2 interactions | 4.72e-04 | 131 | 99 | 5 | int:NHP2 | |
| Interaction | MYB interactions | 5.05e-04 | 133 | 99 | 5 | int:MYB | |
| Interaction | KMT2C interactions | 5.23e-04 | 134 | 99 | 5 | int:KMT2C | |
| Interaction | SMARCE1 interactions | 5.38e-04 | 287 | 99 | 7 | int:SMARCE1 | |
| Interaction | RBBP5 interactions | 5.38e-04 | 287 | 99 | 7 | int:RBBP5 | |
| Interaction | SPAST interactions | 5.60e-04 | 136 | 99 | 5 | int:SPAST | |
| Interaction | DDX42 interactions | 5.68e-04 | 208 | 99 | 6 | int:DDX42 | |
| Interaction | POU5F1 interactions | 5.96e-04 | 584 | 99 | 10 | int:POU5F1 | |
| Interaction | NECAB1 interactions | 6.16e-04 | 34 | 99 | 3 | int:NECAB1 | |
| Interaction | EED interactions | USP36 TPR RANBP2 TBC1D9B TCOF1 NVL CHD3 NUP214 LMNB2 MDM2 MPRIP JARID2 TSC22D1 TMPO RAI14 PJA1 TP53BP1 | 6.34e-04 | 1445 | 99 | 17 | int:EED |
| Interaction | PML interactions | RANBP2 ICE2 SH3GL1 ZNF280B NR3C1 MDM2 CTTNBP2NL KANSL3 CEP170 UBN1 PHF3 TMPO TP53BP1 | 6.39e-04 | 933 | 99 | 13 | int:PML |
| Interaction | ELL interactions | 6.51e-04 | 80 | 99 | 4 | int:ELL | |
| Interaction | IK interactions | 6.75e-04 | 215 | 99 | 6 | int:IK | |
| Interaction | NUP153 interactions | 6.92e-04 | 216 | 99 | 6 | int:NUP153 | |
| Interaction | TRPS1 interactions | 7.03e-04 | 143 | 99 | 5 | int:TRPS1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q12 | 1.56e-03 | 104 | 100 | 3 | chr18q12 | |
| Cytoband | 19q13.31 | 1.84e-03 | 29 | 100 | 2 | 19q13.31 | |
| Cytoband | 19p13.3 | 1.84e-03 | 237 | 100 | 4 | 19p13.3 | |
| GeneFamily | CD molecules|Mucins | 6.53e-15 | 21 | 70 | 8 | 648 | |
| GeneFamily | Nucleoporins | 2.54e-04 | 32 | 70 | 3 | 1051 | |
| GeneFamily | N-BAR domain containing | 9.51e-04 | 12 | 70 | 2 | 1289 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 2.96e-03 | 21 | 70 | 2 | 89 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 SATB2 HIVEP1 CLASP1 NVL APC SPECC1L NR3C1 CLOCK CEP170 JARID2 TIAM1 PIK3C3 PHF3 NAV3 AGFG1 AFF1 TP53BP1 | 3.14e-09 | 856 | 99 | 18 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SATB2 HIVEP1 CLASP1 NVL SPECC1L NR3C1 CLOCK CEP170 JARID2 TIAM1 PIK3C3 PHF3 AFF1 | 2.32e-08 | 466 | 99 | 13 | M13522 |
| Coexpression | NABA_ECM_AFFILIATED | 2.75e-07 | 170 | 99 | 8 | M5880 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | RANBP2 PHACTR2 TBC1D9B PCLO APC SPECC1L NR3C1 MDM2 UBN1 TIAM1 SYT11 AFF1 TSHZ1 MAPRE2 | 1.27e-05 | 946 | 99 | 14 | M39169 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.86e-05 | 300 | 99 | 8 | M8702 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.08e-05 | 158 | 99 | 6 | MM17063 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8_TCELL_DN | 8.84e-05 | 191 | 99 | 6 | M10008 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | KLF12 ZXDA MPRIP CD93 CFAP54 SYT11 PHF3 CBFA2T2 ENAH SLC39A6 | 9.19e-05 | 600 | 99 | 10 | MM1025 |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN | 9.63e-05 | 194 | 99 | 6 | M5393 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 9.99e-05 | 24 | 99 | 3 | MM627 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 9.99e-05 | 24 | 99 | 3 | M1437 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP | 1.02e-04 | 196 | 99 | 6 | M8503 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 1.11e-04 | 199 | 99 | 6 | M8381 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP | 1.14e-04 | 200 | 99 | 6 | M7297 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | KLF12 SATB2 SORBS2 KIF26B CDK12 DAB1 APC NUP214 CTTNBP2NL CEP170 USP31 NFIA PHF3 NAV3 LYPD3 RAI14 TSHZ1 DCLK1 | 1.51e-08 | 769 | 99 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.88e-07 | 209 | 99 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TPR KLF12 CDK12 APC NUP214 USP31 CD93 NFIA PHF3 ENAH CAMSAP1 | 1.83e-06 | 385 | 99 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.99e-06 | 312 | 99 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | SATB2 KIF26B CDK12 DAB1 APC NUP214 CTTNBP2NL USP31 NFIA LYPD3 DCLK1 | 2.07e-06 | 390 | 99 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 3.75e-06 | 89 | 99 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | KLF12 CLASP1 KIF26B DAB1 APC USP31 NFIA SYT11 PHF3 DCLK1 NOVA1 | 4.93e-06 | 427 | 99 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TPR KLF12 KIF26B CDK12 HCN1 APC NUP214 USP31 CD93 NFIA SYT11 PHF3 ENAH CAMSAP1 DCLK1 | 5.67e-06 | 818 | 99 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 6.12e-06 | 209 | 99 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.18e-06 | 97 | 99 | 6 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 6.31e-06 | 149 | 99 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.78e-06 | 369 | 99 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.23e-05 | 165 | 99 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.65e-05 | 397 | 99 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | TPR KLF12 KIF26B CDK12 APC NUP214 CTTNBP2NL USP31 TIAM1 NFIA | 2.05e-05 | 407 | 99 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPR KLF12 CLASP1 KIF26B DAB1 APC NUP214 CTTNBP2NL USP31 NFIA PHF3 LYPD3 PJA1 NOVA1 | 2.19e-05 | 806 | 99 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | TPR KLF12 PHACTR2 KIF26B CDK12 APC NUP214 CTTNBP2NL USP31 CD93 TIAM1 NFIA PHF3 CAMSAP1 | 2.19e-05 | 806 | 99 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.12e-05 | 288 | 99 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.90e-05 | 225 | 99 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | KLF12 PHACTR2 HCN1 APC NUP214 NR3C1 CEP170 USP31 CD93 NFIA PHF3 ENAH PJA1 | 9.98e-05 | 811 | 99 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | KLF12 CLASP1 KIF26B DAB1 APC CEP170 USP31 NFIA SYT11 PHF3 PJA1 DCLK1 NOVA1 | 1.09e-04 | 818 | 99 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 1.43e-04 | 416 | 99 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.57e-04 | 330 | 99 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.98e-04 | 194 | 99 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 3.05e-04 | 69 | 99 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 3.52e-04 | 372 | 99 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 4.19e-04 | 75 | 99 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.60e-04 | 595 | 99 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PHACTR2 HIVEP1 KIF26B MUC16 CHD3 GREB1L TSC22D1 NFIA CD34 TSHZ1 DCLK1 NOVA1 | 4.85e-04 | 831 | 99 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 4.87e-04 | 78 | 99 | 4 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TPR SATB2 ABI3BP KIF26B ICE2 CNKSR2 CHD3 NR3C1 CTTNBP2NL NFIA NAV3 TSHZ1 MUC4 | 6.10e-04 | 978 | 99 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | SORBS2 CLASP1 ICE2 PCLO NCKAP5 MDM2 MPRIP CD93 TIAM1 SYT11 ENAH TP53BP1 NOVA1 | 6.16e-04 | 979 | 99 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.38e-04 | 224 | 99 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 6.48e-04 | 408 | 99 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 6.58e-04 | 409 | 99 | 8 | GSM476663_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPR SATB2 TCOF1 ICE2 APC CNKSR2 CTTNBP2NL GREB1L JARID2 CFAP54 IPCEF1 ENAH TMPO AFF1 CAMSAP1 | 6.71e-04 | 1252 | 99 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TPR SATB2 TCOF1 KIF26B ICE2 PCLO APC PAK6 MDM2 CTTNBP2NL TIAM1 ENAH MUC4 | 6.77e-04 | 989 | 99 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 8.19e-04 | 423 | 99 | 8 | GSM399454_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 8.57e-04 | 40 | 99 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 8.72e-04 | 158 | 99 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.74e-08 | 200 | 100 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.41e-07 | 175 | 100 | 7 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-07 | 179 | 100 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.64e-07 | 179 | 100 | 7 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-07 | 180 | 100 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-07 | 180 | 100 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-07 | 193 | 100 | 7 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.26e-07 | 198 | 100 | 7 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | NS-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.37e-07 | 199 | 100 | 7 | d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.37e-07 | 199 | 100 | 7 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 155 | 100 | 6 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.37e-06 | 170 | 100 | 6 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-06 | 172 | 100 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 174 | 100 | 6 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-06 | 177 | 100 | 6 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 178 | 100 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.62e-06 | 183 | 100 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 3.74e-06 | 184 | 100 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.85e-06 | 185 | 100 | 6 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 186 | 100 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.10e-06 | 187 | 100 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.23e-06 | 188 | 100 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 189 | 100 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.49e-06 | 190 | 100 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 191 | 100 | 6 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 4.63e-06 | 191 | 100 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 100 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 100 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 100 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.92e-06 | 193 | 100 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 4.92e-06 | 193 | 100 | 6 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.06e-06 | 194 | 100 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-06 | 194 | 100 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.06e-06 | 194 | 100 | 6 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.06e-06 | 194 | 100 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 195 | 100 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.22e-06 | 195 | 100 | 6 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 5.37e-06 | 196 | 100 | 6 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.37e-06 | 196 | 100 | 6 | 45d1c0a962c4221c17393ee5566961d1deebf442 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.53e-06 | 197 | 100 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-06 | 198 | 100 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-06 | 198 | 100 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-06 | 198 | 100 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-D|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.69e-06 | 198 | 100 | 6 | fd14efd8e6c74a04bde985c08dc34217c0ef1bab | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-06 | 198 | 100 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 5.86e-06 | 199 | 100 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-06 | 199 | 100 | 6 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.86e-06 | 199 | 100 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 199 | 100 | 6 | a3ec743b978ba8fdf1677b4971b5731f50ddd30f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 5.86e-06 | 199 | 100 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.86e-06 | 199 | 100 | 6 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 199 | 100 | 6 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.86e-06 | 199 | 100 | 6 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.86e-06 | 199 | 100 | 6 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.86e-06 | 199 | 100 | 6 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 5.86e-06 | 199 | 100 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-06 | 199 | 100 | 6 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.03e-06 | 200 | 100 | 6 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.03e-06 | 200 | 100 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.03e-06 | 200 | 100 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.03e-06 | 200 | 100 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | 5'-Airway_Nasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.03e-06 | 200 | 100 | 6 | f6e967738b4f7b173d6e9977e305f77380dd6c8a | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.03e-06 | 200 | 100 | 6 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 6.03e-06 | 200 | 100 | 6 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | (5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.03e-06 | 200 | 100 | 6 | 75e5ecb05e965e24d569aa2ef5cdf740b1528c06 | |
| ToppCell | 5'-Airway_Nasal-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.03e-06 | 200 | 100 | 6 | 358d71329921451c7f5a56f1db0f9989af2299dc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.03e-06 | 200 | 100 | 6 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | (15)_Treg|World / shred on Cell_type and subtype | 7.34e-06 | 207 | 100 | 6 | 83bae0389269077434d1e5ab53205ae569ff4479 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.88e-05 | 70 | 100 | 4 | 2121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.88e-05 | 70 | 100 | 4 | cd6bca68fe52f451716fc8c0b1745984bc9ec057 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.88e-05 | 70 | 100 | 4 | be300c0447735aba89df4c3082b81eb5abf22770 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 150 | 100 | 5 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 2.63e-05 | 155 | 100 | 5 | 85eb60d285b8bfc095c341ae90c0e3b7e7dca9c1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-05 | 159 | 100 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.97e-05 | 159 | 100 | 5 | 31ec8222c766cb614e1cf27f74ee9d99489eca5c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.16e-05 | 161 | 100 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-05 | 161 | 100 | 5 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.25e-05 | 162 | 100 | 5 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.25e-05 | 162 | 100 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.45e-05 | 164 | 100 | 5 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | T_cells-TFH-like_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.45e-05 | 164 | 100 | 5 | b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-05 | 166 | 100 | 5 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-05 | 166 | 100 | 5 | 1cc291a04f4144abba4aca7badeb7776db05d903 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 3.98e-05 | 169 | 100 | 5 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-05 | 173 | 100 | 5 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.82e-05 | 176 | 100 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.82e-05 | 176 | 100 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.09e-05 | 178 | 100 | 5 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 179 | 100 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.23e-05 | 179 | 100 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 5.23e-05 | 179 | 100 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.37e-05 | 180 | 100 | 5 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Club-club-8|World / Class top | 5.66e-05 | 182 | 100 | 5 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 182 | 100 | 5 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 182 | 100 | 5 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 5.80e-05 | 183 | 100 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Computational | Nuclear pore complex. | 1.29e-04 | 17 | 64 | 3 | MODULE_352 | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 2.47e-06 | 198 | 99 | 8 | 4301_UP | |
| Drug | geldanamycin | USP36 TPR KLF12 PHACTR2 HCN1 ICE2 MDM2 AGFG1 SLC39A6 TP53BP1 | 5.03e-06 | 371 | 99 | 10 | ctd:C001277 |
| Drug | cucurbitacins | 1.71e-05 | 12 | 99 | 3 | CID000119287 | |
| Drug | cellobiitol | 1.99e-05 | 37 | 99 | 4 | CID000003871 | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.03e-05 | 191 | 99 | 7 | 3926_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.17e-05 | 193 | 99 | 7 | 5922_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.25e-05 | 194 | 99 | 7 | 4727_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 2.25e-05 | 194 | 99 | 7 | 4141_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.25e-05 | 194 | 99 | 7 | 4312_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 7027_DN | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 5962_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 6311_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 1532_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 5249_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 5285_DN | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 5446_UP | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 7317_UP | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 4830_UP | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 4131_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 6630_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.73e-05 | 200 | 99 | 7 | 5502_UP | |
| Drug | 2,4,2',4'-tetrachlorobiphenyl | 3.49e-05 | 15 | 99 | 3 | ctd:C035976 | |
| Drug | Magnetite Nanoparticles | SORBS2 HIVEP1 CDK12 NVL NR3C1 MDM2 ZNF831 CTTNBP2NL CEP170 CD93 TSC22D1 PHF3 CBFA2T2 TMPO MAPRE2 UTY MUC20 | 4.65e-05 | 1310 | 99 | 17 | ctd:D058185 |
| Drug | AC1NE2UB | 1.04e-04 | 56 | 99 | 4 | CID004635684 | |
| Drug | Succimer | SORBS2 HIVEP1 CDK12 NR3C1 MDM2 ZNF831 CTTNBP2NL CEP170 CD93 TSC22D1 PHF3 CBFA2T2 TMPO MAPRE2 UTY MUC20 | 1.07e-04 | 1264 | 99 | 16 | ctd:D004113 |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.29e-04 | 178 | 99 | 6 | 3998_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.50e-04 | 183 | 99 | 6 | 7498_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 1.59e-04 | 185 | 99 | 6 | 1226_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.69e-04 | 187 | 99 | 6 | 4323_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.69e-04 | 187 | 99 | 6 | 5258_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.79e-04 | 189 | 99 | 6 | 5586_UP | |
| Drug | celecoxib; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.79e-04 | 189 | 99 | 6 | 922_UP | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.84e-04 | 190 | 99 | 6 | 4306_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.84e-04 | 190 | 99 | 6 | 4322_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.84e-04 | 190 | 99 | 6 | 2869_DN | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 1.84e-04 | 190 | 99 | 6 | 1103_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.89e-04 | 191 | 99 | 6 | 3582_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.95e-04 | 192 | 99 | 6 | 4268_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.95e-04 | 192 | 99 | 6 | 4104_DN | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 7176_UP | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 4225_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 4129_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 3606_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 6779_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 4309_DN | |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 7152_DN | |
| Drug | 5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.12e-04 | 195 | 99 | 6 | 920_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 6918_UP | |
| Drug | Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 3869_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 4813_UP | |
| Drug | AC1MNNW3 | 2.16e-04 | 27 | 99 | 3 | CID003355727 | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 4423_DN | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 4629_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 3314_UP | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 2734_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; PC3; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 5828_UP | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; HL60; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 6130_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 5974_DN | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 5806_DN | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 4097_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 4556_DN | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 6747_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3581_UP | |
| Drug | Vinpocetine [42971-09-5]; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 5859_UP | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3859_UP | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 4198_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 4992_UP | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 7301_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 2059_DN | |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 4530_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 4603_UP | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 3797_UP | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; HL60; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 3035_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; HL60; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 2342_UP | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 5682_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 5414_UP | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6327_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 4432_DN | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 3239_UP | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 3264_UP | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 2309_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 5384_UP | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 5415_UP | |
| Drug | Spaglumic acid [4910-46-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 7465_UP | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 4633_UP | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 3764_UP | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 4197_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.42e-04 | 200 | 99 | 6 | 7129_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.42e-04 | 200 | 99 | 6 | 1238_UP | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | 2.42e-04 | 200 | 99 | 6 | 5510_DN | |
| Drug | deoxynivalenol | 2.51e-04 | 481 | 99 | 9 | ctd:C007262 | |
| Drug | benz(a)anthracene | TPR KLF12 ABI3BP TCOF1 KIF26B PCLO GCM1 NR3C1 MDM2 CLOCK CHRNA4 TSC22D1 CD34 DOT1L MUC4 | 3.22e-04 | 1251 | 99 | 15 | ctd:C030935 |
| Drug | glufosinate | 3.39e-04 | 76 | 99 | 4 | CID000004794 | |
| Disease | cholangiocarcinoma (is_marker_for) | 6.94e-08 | 64 | 97 | 6 | DOID:4947 (is_marker_for) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 1.19e-06 | 7 | 97 | 3 | DOID:0050625 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.78e-06 | 61 | 97 | 5 | DOID:3587 (is_marker_for) | |
| Disease | keratoconjunctivitis (is_marker_for) | 3.20e-05 | 3 | 97 | 2 | DOID:9368 (is_marker_for) | |
| Disease | neuroimaging measurement | KIF26B DAB1 APC NCKAP5 CNKSR2 PAK6 RGP1 NFIA CBFA2T2 NAV3 AFF1 MAPRE2 DCLK1 | 4.79e-05 | 1069 | 97 | 13 | EFO_0004346 |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 6.39e-05 | 4 | 97 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | Neoplastic Cell Transformation | 9.82e-05 | 139 | 97 | 5 | C0007621 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.06e-04 | 5 | 97 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Intellectual Disability | 1.16e-04 | 447 | 97 | 8 | C3714756 | |
| Disease | cortical surface area measurement | SATB2 KIF26B DAB1 APC NCKAP5 RGP1 MPRIP NFIA NAV3 AGFG1 AFF1 MAPRE2 DCLK1 NOVA1 | 1.27e-04 | 1345 | 97 | 14 | EFO_0010736 |
| Disease | Major Depressive Disorder | 1.55e-04 | 243 | 97 | 6 | C1269683 | |
| Disease | Mental Depression | 1.97e-04 | 254 | 97 | 6 | C0011570 | |
| Disease | Unipolar Depression | 2.19e-04 | 259 | 97 | 6 | C0041696 | |
| Disease | Ischemic stroke, coronary artery disease | 2.46e-04 | 92 | 97 | 4 | EFO_0001645, HP_0002140 | |
| Disease | bulimia nervosa | 2.89e-04 | 39 | 97 | 3 | EFO_0005204 | |
| Disease | common bile duct neoplasm (is_marker_for) | 2.96e-04 | 8 | 97 | 2 | DOID:4608 (is_marker_for) | |
| Disease | brain connectivity measurement | 3.60e-04 | 400 | 97 | 7 | EFO_0005210 | |
| Disease | Depressive disorder | 3.93e-04 | 289 | 97 | 6 | C0011581 | |
| Disease | soluble triggering receptor expressed on myeloid cells 2 measurement | 4.46e-04 | 296 | 97 | 6 | EFO_0010151 | |
| Disease | obsolete_red blood cell distribution width | LVRN USP36 CLASP1 CDK12 SH3GL1 NVL RGP1 CEP170 MUC17 CBFA2T2 CLPTM1 MAPRE2 MUC4 | 4.65e-04 | 1347 | 97 | 13 | EFO_0005192 |
| Disease | dry eye syndrome (is_marker_for) | 4.73e-04 | 10 | 97 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 4.73e-04 | 10 | 97 | 2 | DOID:10754 (is_marker_for) | |
| Disease | hematocrit | HIVEP1 SH3GL1 CHD3 SORBS1 NR3C1 MPRIP NFIA AFF1 RAI14 DOT1L TP53BP1 | 4.90e-04 | 1011 | 97 | 11 | EFO_0004348 |
| Disease | Colorectal Carcinoma | 5.15e-04 | 702 | 97 | 9 | C0009402 | |
| Disease | coronary artery disease | SORBS2 CDK12 HCN1 DAB1 CNKSR2 LMNB2 SPECC1L ZNF831 CLOCK NT5C1B NFIA MAPRE2 | 5.46e-04 | 1194 | 97 | 12 | EFO_0001645 |
| Disease | Macrocephaly | 5.77e-04 | 11 | 97 | 2 | C0221355 | |
| Disease | pulmonary fibrosis | 5.77e-04 | 11 | 97 | 2 | EFO_0009448 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 6.40e-04 | 51 | 97 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | Schizophrenia | KLF12 DISC1 APC NR3C1 CLOCK CHRNA4 JARID2 SYT11 PIK3C3 DCLK1 | 6.58e-04 | 883 | 97 | 10 | C0036341 |
| Disease | thyroid gland carcinoma (is_marker_for) | 6.91e-04 | 12 | 97 | 2 | DOID:3963 (is_marker_for) | |
| Disease | brain disease (is_implicated_in) | 6.91e-04 | 12 | 97 | 2 | DOID:936 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | SORBS2 ICE2 SPECC1L MPRIP SYT11 ENAH AFF1 TSHZ1 MAPRE2 TP53BP1 | 8.56e-04 | 914 | 97 | 10 | EFO_0004532 |
| Disease | asthma, body mass index | 9.49e-04 | 14 | 97 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 1.09e-03 | 15 | 97 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | PR interval | 1.26e-03 | 495 | 97 | 7 | EFO_0004462 | |
| Disease | major depressive disorder (is_implicated_in) | 1.41e-03 | 17 | 97 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | 1-Methylhistidine measurement | 1.41e-03 | 17 | 97 | 2 | EFO_0021543 | |
| Disease | Acute myeloid leukemia | 1.41e-03 | 17 | 97 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.41e-03 | 17 | 97 | 2 | 601626 | |
| Disease | otitis media (biomarker_via_orthology) | 1.41e-03 | 17 | 97 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | sinusitis (is_marker_for) | 1.58e-03 | 18 | 97 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | unipolar depression, response to bupropion, mood disorder | 1.76e-03 | 19 | 97 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.78e-03 | 156 | 97 | 4 | C0007131 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 2.37e-03 | 22 | 97 | 2 | EFO_0009312 | |
| Disease | JT interval, response to sulfonylurea | 2.59e-03 | 23 | 97 | 2 | EFO_0007885, EFO_0007922 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.82e-03 | 24 | 97 | 2 | DOID:12894 (is_marker_for) | |
| Disease | systemic mastocytosis | 3.05e-03 | 25 | 97 | 2 | MONDO_0016586 | |
| Disease | blood tin measurement | 3.05e-03 | 25 | 97 | 2 | EFO_0021530 | |
| Disease | alcohol dependence | 3.17e-03 | 183 | 97 | 4 | MONDO_0007079 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITSLTPGESKTTSPS | 136 | Q9BT88 | |
| TVSTSDSEPSLPRSK | 521 | Q86YH2 | |
| KLPSSSTSSRTPSTS | 146 | Q96P26 | |
| VVSGSSSKSTTLPRP | 1081 | Q5SW79 | |
| SSLTSSPCSSPVLTK | 421 | Q9P2B4 | |
| EPSSVSPSATVKTRS | 536 | P43681 | |
| TSRSPPESKGSSRSS | 31 | Q96N23 | |
| PPSKTSRKETTSGTS | 1061 | Q9NYV4 | |
| SSIPSVSDTSTPRRS | 2141 | Q15878 | |
| TSTPTREDSSSTPLQ | 1236 | Q8N7X0 | |
| KATPTTSRPSLSSDA | 511 | Q9NPY3 | |
| SSTSSEPTPTVKTLI | 831 | Q69YQ0 | |
| TAISSPETSLKSSPV | 1141 | Q8TEK3 | |
| KPSSARELAVTTTPS | 71 | Q6Q4G3 | |
| VRTATVSSPLTSPTS | 266 | Q9UBW5 | |
| TSPTSPSTLSLKSES | 276 | Q9UBW5 | |
| GSSRSKTPTPSVETL | 1116 | Q5T5Y3 | |
| RSPVSKSAAAPTVTS | 96 | Q9NRI5 | |
| PALRSTATTPTATSV | 1966 | Q9HC84 | |
| TTATSRTTATATPSK | 2276 | Q9HC84 | |
| ATPSKTRTSTLLPSS | 2286 | Q9HC84 | |
| SKTRTSTLLPSSPTS | 2846 | Q9HC84 | |
| SSSSPRTATTLPVLT | 3041 | Q9HC84 | |
| SKTRTSTLLPSSPTS | 3546 | Q9HC84 | |
| TATSRTTATATPSKT | 4091 | Q9HC84 | |
| TTATATPSKTRTSTL | 4096 | Q9HC84 | |
| VLTSPATTPTATSSK | 4281 | Q9HC84 | |
| ATSSSSPRTATTLPV | 4296 | Q9HC84 | |
| PAATSSKATSSSSPR | 4716 | Q9HC84 | |
| SKATSSSSPRTATTL | 4721 | Q9HC84 | |
| SSSPRTATTLPVLTS | 4726 | Q9HC84 | |
| LPSTSSTSSTKRLKS | 266 | Q12857 | |
| SDVSSPRSITSTPLS | 286 | Q9P0K7 | |
| VSTPASSETSKAPKS | 1701 | P49792 | |
| PDSITKSISSPSVSS | 2796 | P49792 | |
| TTSSTPRISSKTGSI | 146 | O15381 | |
| RTLSPSDTTASTPIS | 3661 | Q8WXI7 | |
| SPPSVEKTSSSSSLL | 6501 | Q8WXI7 | |
| PETSTETITRLPTSS | 8176 | Q8WXI7 | |
| SVEKTSPPSSLVSLS | 8846 | Q8WXI7 | |
| TTPLPVTDTSSASTR | 3886 | Q99102 | |
| LTTSDTSSPQKSLRT | 321 | Q9NQU5 | |
| SSSSIPSAEKVPTTK | 186 | Q6WCQ1 | |
| SRSSTPLPTISSSAE | 156 | P42166 | |
| RLAKKPSTAPSTSTT | 366 | O60721 | |
| PVITPSRASESSASS | 261 | Q8N307 | |
| PVITPSRASESSASS | 356 | Q8N307 | |
| PSPSSRVTVSRATSS | 406 | Q03252 | |
| SSTENSVKTPASPTR | 141 | A0A0K2S4Q6 | |
| RGPSASTTKTLSFST | 1746 | Q2KJY2 | |
| PSRRSKSPASTSSVN | 301 | O15075 | |
| PSPALDKTSATTSRS | 576 | O43439 | |
| LVSSSSATTKPDIPS | 766 | Q9Y6V0 | |
| ASSSARTKPTSLPIS | 4331 | Q9Y6V0 | |
| RPTFVSTLSTPTSSL | 511 | Q02505 | |
| SATTPSLRPTITSTD | 1256 | Q02505 | |
| PPTSSLVSTAETAKT | 1496 | Q02505 | |
| SPKTTTLTPTSDIST | 1736 | Q02505 | |
| TPSSLSTDIPTTSLR | 2476 | Q02505 | |
| SSSLPTILRTSSKST | 2896 | Q02505 | |
| KQSSTATSPTPSSDR | 351 | Q8IVL0 | |
| STISKSSRAVSASSP | 586 | Q96LU7 | |
| TALSTTSSKLETPPS | 1301 | P35658 | |
| RSTSVPENPKSSAST | 131 | P04150 | |
| SRSSTPLPTISSSAE | 156 | P42167 | |
| TPPTTSKTTETRASG | 1491 | P98088 | |
| TSAPTTRTTSAPKSS | 2461 | P98088 | |
| PRRTSAPTTSTISAS | 2746 | P98088 | |
| ASPSTSSTSSRPKAS | 236 | O75167 | |
| STTSKPSSSSSGPRT | 1196 | Q9C091 | |
| TTSTSAPVRPTSTTK | 256 | O95274 | |
| SSTTTPTSRMRTQSP | 651 | O60741 | |
| TKVSKSPSPASTSTV | 411 | Q659A1 | |
| TPSSFPSSLSKERQS | 206 | Q8WWN9 | |
| TSDSTRSSPQTDKPR | 426 | O75553 | |
| PAASPESRKSARTTS | 261 | Q96JM3 | |
| PSADSKRSSRASSPT | 1521 | Q12873 | |
| KRSSRASSPTKTSPT | 1526 | Q12873 | |
| PSSVSLSLKGSTETR | 176 | Q9NP62 | |
| RASSSKESPSPSVRE | 521 | Q5T0F9 | |
| LETSKRPPSGTSTTS | 716 | Q68DC2 | |
| STPSRPSSAKRASSS | 216 | Q15555 | |
| SSVSSSPTSSPKTKV | 531 | Q9P2N6 | |
| SPTSSPKTKVTTVTS | 536 | Q9P2N6 | |
| INKARTSPTAVSSSP | 86 | Q9Y4X4 | |
| TSKASSTSTPEPTRK | 481 | Q8N8S7 | |
| LSTTSTSLATSPTKP | 146 | P28906 | |
| VDVPPSRLSASSSSK | 1226 | Q92833 | |
| TTTKSSPSDPMTTSR | 156 | P51513 | |
| RTPVTTSAEASSSPT | 2956 | Q685J3 | |
| TLSRTPADTSTPVTT | 3006 | Q685J3 | |
| TKPSTRTTSFPTVTT | 4096 | Q685J3 | |
| STATPSPKSTEQRSI | 771 | O14607 | |
| ATPKLDSSPSVSSTL | 1221 | Q13428 | |
| PSSTKSETRVPSETA | 951 | O14513 | |
| TTRTSFSLPIPLSST | 296 | Q92546 | |
| TTLSSTSLSIPERSP | 526 | O60331 | |
| PTKTPGRTSSTLSED | 156 | Q8NEB9 | |
| KPSSSHLVSRPSTSS | 146 | Q00987 | |
| SSSRTPQAKTSTPTT | 456 | Q9UPW6 | |
| SPVSRKLSTTGSSDS | 256 | Q15714 | |
| TTTKEPTSTTSDKPA | 736 | Q92954 | |
| LTKSFTSSSPSSPSR | 291 | O94875 | |
| KDVSSSTPPSVTSKS | 216 | Q13433 | |
| DSSSVLPSPLSISTK | 356 | Q66K14 | |
| ESSKTKPSRPSSQSS | 846 | P51825 | |
| SSASSTSSTPEVKPL | 146 | P52594 | |
| PRTSSPSTASTKSSG | 2346 | P25054 | |
| HSPTPSASSRSSRKS | 426 | O15516 | |
| TATREEASTSLPTKP | 631 | O96005 | |
| SSTSSKAPPSSRRNV | 256 | Q7Z460 | |
| ATPSSTISTPTKRDS | 331 | Q8WXI2 | |
| TSLPSVAPSKTKSSS | 251 | Q9HCE3 | |
| SSSFRSSDKPIRTPS | 286 | Q99961 | |
| NSEVSTRSSSTPSIP | 51 | Q13009 | |
| KSTSTKRAPSNRPSS | 66 | B3KS81 | |
| TTSKATLPGERSSSS | 696 | B3KS81 | |
| VSLASTPKRPSTSQT | 636 | P12270 | |
| RPSSSASTKDSESPR | 701 | Q9BX66 | |
| PTASLTRTPSTASLT | 521 | Q9UF83 | |
| PSKSITFTSRSTSPR | 1776 | Q92576 | |
| ASSSSSTTPTRKITE | 1641 | Q12888 | |
| TPSSKLTVDTDTLTP | 721 | P98168 | |
| PSLKPSAVSSVTSST | 991 | Q9NPG3 | |
| STTKRSPSSKGTSEP | 1021 | Q70CQ4 | |
| GRTLTSSSPDSKVTE | 1521 | Q5JPB2 | |
| PRSTKPTTSSALDVS | 336 | Q7Z7G0 | |
| PSQTTKRSRSPFSTT | 61 | Q8NG27 | |
| RRTSSSSDIPKSPFT | 801 | P15822 | |
| LTPKSSTPSTVSEKS | 851 | Q6ZSZ6 | |
| KSPVLSNTTTEPAST | 666 | Q9P275 | |
| ESTPSRLSPSSTETT | 1411 | Q9UKN1 | |
| RSPDTTLSPASTTSS | 3256 | Q9UKN1 | |
| ESTPSRLSPSSTETT | 4051 | Q9UKN1 | |
| TTATTTPRQKVAPSS | 1126 | Q9NR99 |